In line with this finding, a large proportion (8/9) of CRC patients under the age of 45, a majority of whom expressed high levels of BRCA1 mRNA, harbored TP53 mutations in their tumors (Supplementary Table 2). This evidence concerns the gene TP53 and colorectal carcinoma.